About IJCPCR

THE PREVALENCE OF CUTANEOUS ASPERGILLOSIS IN AN IMMUNOCOMMPROMISED PATIENTS
Article Information
Language
Corres.Author
Email
Accepted Date
File size
No of Downloads
Published by
Full Text
Primary cutaneous aspergillosis in immunocompromised patients has been well described in extensive investigations. Though in immunocompetent hosts, primary cutaneous infection of aspergillus occurs rarely and residue poorly characterized in connected with Aspergillosis. This aim of the study the prevalence of cutaneous aspergillosis in an immunocompromised patient. Material methods: Cutaneous aspergillosis” was conducted March 16, 2021. Only patient history that provided the subsequent in order were integrated in this examination: patient baseline distinctiveness such as age, sex, underlying condition evidence of confirmed PCA. Results: Out of 120 patients were 82 male (68.3%). The mean was 29.4, ± 30. Ages ranged from infants to 81 years. The most popular of patients were adults from between 18 and 65 years of age. An array of underlying situation were encountered, the most frequent being blood malignancy (87.5%), followed by HIV/ AIDS (32.5%) and neonatal status (23.3%). Here 13.3%A of cases were reported with no diagnosed risk factors. Conclusion: Primary cutaneous aspergillosis may possibly arise in immunocompetent hosts. The preliminary lesions may come out in dissimilar forms such as macules, papules, nodules, and oplaques. Repeated biopsy, both culture and histopathology is considered necessaryddd